LOOKING FOR THE BEST SOLUTIONS FOR THE DEVELOPMENT OF NEW PRODUCTS
Unraveling the Abbreviated Development Path
Publication of the Public Consultation for the review of RDC 200 - what is new?
NEW REGULATORY FRAMEWORK OF API: Which questions were answered in the new ALADIP manual?
In order to meet all the requirements of the new GMP legislation, we have expanded our portfolio of services in the area of Quality.
WHO WE ARE
We are a service consultancy in the area of medicines and health products with great expertise in all stages of new product development
We work with healthcare companies of all sizes with some of the largest pharmaceutical companies in Brazil and the world in our portfolio.
Out of gallery
Cannabis: challenges and opportunities
API, BPF and drug dossier - How to align the processes to ensure success in registration?
NEW API REGULATORY FRAMEWORK: Will ANVISA and international manufacturers be prepared?